Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients

Authors: Przemysław Pencak, Beata Czerwieńska, Rafał Ficek, Katarzyna Wyskida, Agata Kujawa-Szewieczek, Magdalena Olszanecka-Glinianowicz, Andrzej Więcek, Jerzy Chudek

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Process of accelerated atherosclerosis specific for uremia increases cardiovascular risk in patients with chronic kidney disease (CKD) and may be influenced by the different structure of arteries. The study assesses the influence of traditional and novel risk factors on calcification of coronary arteries (CAC) and abdominal aorta (AAC) in hemodialysis patients (HD).

Methods

CAC and AAC were assessed by CT in 104 prevalent adult HD and 14 apparently healthy subjects with normal kidney function (control group). Mineral metabolism parameters, plasma levels of FGF-23, MGP, osteoprotegerin, osteopontin, fetuin-A, CRP, IL-6 and TNF-α were measured.

Results

CAC and AAC (calcification score ≥ 1) were found in 76 (73.1%) and 83 (79.8%) HD respectively, more frequent than in the control group. In 7 HD with AAC no CAC were detected. The frequency and severity of calcifications increased with age. Both CAC and AAC were more frequently detected in diabetics (OR = 17.37 and 13.00, respectively). CAC score was significantly greater in males. CAC and AAC scores were correlated significantly with pack-years of smoking and plasma osteoprotegrin levels. However the independent contribution of plasma osteoprotegerin levels was not confirmed in multiple regression analysis. Age (OR = 1.13) and hemodialysis vintage (OR = 1.14) were the independent risk factor favoring the occurrence of CAC; while age (OR = 1.20) was the only predictor of AAC occurrence in HD.

Conclusions

1. AAC precedes the occurrence of CAC in HD patients. 2. The exposition to uremic milieu and systemic chronic microinflammation has more deteriorative effect on the CAC than the AAC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998, 9 (12 Suppl): S16-S23.PubMed Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998, 9 (12 Suppl): S16-S23.PubMed
2.
go back to reference Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974, 290: 697-701. 10.1056/NEJM197403282901301.CrossRefPubMed Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974, 290: 697-701. 10.1056/NEJM197403282901301.CrossRefPubMed
3.
go back to reference Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994, 93: 2393-2402. 10.1172/JCI117246.CrossRefPubMedPubMedCentral Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994, 93: 2393-2402. 10.1172/JCI117246.CrossRefPubMedPubMedCentral
4.
go back to reference Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL: Multilineage potential of cells from the artery wall. Circulation. 2003, 108: 2505-2510. 10.1161/01.CIR.0000096485.64373.C5.CrossRefPubMed Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL: Multilineage potential of cells from the artery wall. Circulation. 2003, 108: 2505-2510. 10.1161/01.CIR.0000096485.64373.C5.CrossRefPubMed
5.
go back to reference Mizobuchi M, Towler D, Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009, 20: 1453-1464. 10.1681/ASN.2008070692.CrossRefPubMed Mizobuchi M, Towler D, Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009, 20: 1453-1464. 10.1681/ASN.2008070692.CrossRefPubMed
6.
go back to reference Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. J Am Soc Nephrol. 2008, 3 (2): 505-521. 10.2215/CJN.03670807.CrossRef Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z: Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. J Am Soc Nephrol. 2008, 3 (2): 505-521. 10.2215/CJN.03670807.CrossRef
7.
go back to reference Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005, 293 (14): 1737-1745. 10.1001/jama.293.14.1737.CrossRefPubMed Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005, 293 (14): 1737-1745. 10.1001/jama.293.14.1737.CrossRefPubMed
8.
go back to reference Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electron beam computed tomography calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999, 74: 242-252. 10.4065/74.3.242.CrossRef Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electron beam computed tomography calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999, 74: 242-252. 10.4065/74.3.242.CrossRef
9.
go back to reference Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996, 27 (3): 394-401. 10.1016/S0272-6386(96)90363-7.CrossRefPubMed Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996, 27 (3): 394-401. 10.1016/S0272-6386(96)90363-7.CrossRefPubMed
10.
go back to reference Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol. 2002, 39 (4): 695-701. 10.1016/S0735-1097(01)01781-8.CrossRefPubMed Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol. 2002, 39 (4): 695-701. 10.1016/S0735-1097(01)01781-8.CrossRefPubMed
11.
go back to reference Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML, Corsini S, Fattori R, Russo V, Nastasi V, Colì L, Wratten M, Stefoni S: Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?. Blood Purif. 2010, 29 (1): 13-22. 10.1159/000245042.CrossRefPubMed Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML, Corsini S, Fattori R, Russo V, Nastasi V, Colì L, Wratten M, Stefoni S: Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?. Blood Purif. 2010, 29 (1): 13-22. 10.1159/000245042.CrossRefPubMed
12.
go back to reference Kraśniak A, Drozdz M, Pasowicz M, Chmiel G, Michałek M, Szumilak D, Podolec P, Klimeczek P, Konieczyńska M, Wicher-Muniak E, Tracz W, Khoa TN, Souberbielle JC, Drueke TB, Sulowicz W: Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant. 2007, 22 (2): 515-521.CrossRefPubMed Kraśniak A, Drozdz M, Pasowicz M, Chmiel G, Michałek M, Szumilak D, Podolec P, Klimeczek P, Konieczyńska M, Wicher-Muniak E, Tracz W, Khoa TN, Souberbielle JC, Drueke TB, Sulowicz W: Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant. 2007, 22 (2): 515-521.CrossRefPubMed
13.
go back to reference Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000, 342 (20): 1478-1483. 10.1056/NEJM200005183422003.CrossRefPubMed Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000, 342 (20): 1478-1483. 10.1056/NEJM200005183422003.CrossRefPubMed
14.
go back to reference Nitta K, Akiba T, Suzuki K, Uchida K, Ogawa T, Majima K, Watanabe R, Aoki T, Nihei H: Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res. 2004, 27 (8): 527-533. 10.1291/hypres.27.527.CrossRefPubMed Nitta K, Akiba T, Suzuki K, Uchida K, Ogawa T, Majima K, Watanabe R, Aoki T, Nihei H: Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res. 2004, 27 (8): 527-533. 10.1291/hypres.27.527.CrossRefPubMed
15.
go back to reference Ohtake T, Ishioka K, Honda K, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Hidaka S, Kobayashi S: Impact of coronary artery calcification in hemodialysis patients: risk factors and associations with prognosis. Hemodial Int. 2010, 14 (2): 218-225. 10.1111/j.1542-4758.2009.00423.x.CrossRefPubMed Ohtake T, Ishioka K, Honda K, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Hidaka S, Kobayashi S: Impact of coronary artery calcification in hemodialysis patients: risk factors and associations with prognosis. Hemodial Int. 2010, 14 (2): 218-225. 10.1111/j.1542-4758.2009.00423.x.CrossRefPubMed
16.
go back to reference Karamanidou C, Clatworthy J, Weinman J, Horne R: A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008, 9: 2-10.1186/1471-2369-9-2.CrossRefPubMedPubMedCentral Karamanidou C, Clatworthy J, Weinman J, Horne R: A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008, 9: 2-10.1186/1471-2369-9-2.CrossRefPubMedPubMedCentral
17.
go back to reference London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004, 15 (7): 1943-1951. 10.1097/01.ASN.0000129337.50739.48.CrossRefPubMed London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004, 15 (7): 1943-1951. 10.1097/01.ASN.0000129337.50739.48.CrossRefPubMed
18.
go back to reference Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED: Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011, 26 (6): 945-951. 10.1007/s00467-011-1822-0.CrossRefPubMed Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED: Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011, 26 (6): 945-951. 10.1007/s00467-011-1822-0.CrossRefPubMed
19.
go back to reference Jakuszewski P, Czerwieńska B, Chudek J, Wiecek A: Which components of malnutrition-inflammation-atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy?. Nephrology (Carlton). 2009, 14 (7): 643-649. 10.1111/j.1440-1797.2009.01096.x.CrossRef Jakuszewski P, Czerwieńska B, Chudek J, Wiecek A: Which components of malnutrition-inflammation-atherosclerosis syndrome are more common in haemodialysis patients with diabetic nephropathy?. Nephrology (Carlton). 2009, 14 (7): 643-649. 10.1111/j.1440-1797.2009.01096.x.CrossRef
20.
go back to reference Tintut Y, Patel J, Parhami F, Demer LL: Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000, 102 (21): 2636-2642. 10.1161/01.CIR.102.21.2636.CrossRefPubMed Tintut Y, Patel J, Parhami F, Demer LL: Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000, 102 (21): 2636-2642. 10.1161/01.CIR.102.21.2636.CrossRefPubMed
21.
go back to reference Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Cendoroglo M, Draibe SA, Moyses RM, Neves KR, Jorgetti V, Blair A, Guiberteau R, Fernandes Canziani ME: Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005, 67 (4): 1576-1582. 10.1111/j.1523-1755.2005.00239.x.CrossRefPubMed Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Cendoroglo M, Draibe SA, Moyses RM, Neves KR, Jorgetti V, Blair A, Guiberteau R, Fernandes Canziani ME: Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005, 67 (4): 1576-1582. 10.1111/j.1523-1755.2005.00239.x.CrossRefPubMed
22.
go back to reference Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A: Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol. 2012, 7 (6): 965-973. 10.2215/CJN.11191111.CrossRefPubMedPubMedCentral Ozkok A, Caliskan Y, Sakaci T, Erten G, Karahan G, Ozel A, Unsal A, Yildiz A: Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol. 2012, 7 (6): 965-973. 10.2215/CJN.11191111.CrossRefPubMedPubMedCentral
23.
go back to reference Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007, 49 (3): 417-425. 10.1053/j.ajkd.2006.12.017.CrossRefPubMed Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007, 49 (3): 417-425. 10.1053/j.ajkd.2006.12.017.CrossRefPubMed
24.
go back to reference Honkanen E, Kauppila L, Wikström B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B, CORD study group: Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant. 2008, 23 (12): 4009-4015. 10.1093/ndt/gfn403.CrossRefPubMedPubMedCentral Honkanen E, Kauppila L, Wikström B, Rensma PL, Krzesinski JM, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B, CORD study group: Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant. 2008, 23 (12): 4009-4015. 10.1093/ndt/gfn403.CrossRefPubMedPubMedCentral
25.
go back to reference Allison MA, Budoff MJ, Nasir K, Wong ND, Detrano R, Kronmal R, Takasu J, Criqui MH: Ethnic-specific risks for atherosclerotic calcification of the thoracic and abdominal aorta (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2009, 104 (6): 812-817. 10.1016/j.amjcard.2009.05.004.CrossRefPubMedPubMedCentral Allison MA, Budoff MJ, Nasir K, Wong ND, Detrano R, Kronmal R, Takasu J, Criqui MH: Ethnic-specific risks for atherosclerotic calcification of the thoracic and abdominal aorta (from the multi-ethnic study of atherosclerosis). Am J Cardiol. 2009, 104 (6): 812-817. 10.1016/j.amjcard.2009.05.004.CrossRefPubMedPubMedCentral
26.
go back to reference Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant. 2010, 25 (8): 2679-2685. 10.1093/ndt/gfq089.CrossRefPubMed Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant. 2010, 25 (8): 2679-2685. 10.1093/ndt/gfq089.CrossRefPubMed
27.
go back to reference Shiota J, Izumi N, Kasahara H, Tagawa H, Chiba T, Nihei H: Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients. Nihon Jinzo Gakkai Shi. 2010, 52 (8): 1022-1028.PubMed Shiota J, Izumi N, Kasahara H, Tagawa H, Chiba T, Nihei H: Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients. Nihon Jinzo Gakkai Shi. 2010, 52 (8): 1022-1028.PubMed
Metadata
Title
Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients
Authors
Przemysław Pencak
Beata Czerwieńska
Rafał Ficek
Katarzyna Wyskida
Agata Kujawa-Szewieczek
Magdalena Olszanecka-Glinianowicz
Andrzej Więcek
Jerzy Chudek
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-10

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.